Clinical Trial Update: 5-strain Probiotic Formulation in HR-positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone Loss [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a five-strain probiotic formulation to prevent bone loss in patients with hormone receptor-positive breast cancer receiving ar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Osteoporosis

Drugs mentioned

• 5-strain probiotic formulation

Snippet

Sponsor: Mayo Clinic | Conditions: Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 | Phase 2 | Status: RECRUITING